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1. Introduction
Tissue and organ failure treatments include drug therapy, surgical repair, medical devices
but they do not always provide satisfactory restoration of organ function.
At present transplants represent an actual solution in treating organ failure once overcom‐
ing immunological rejection even though its application is largely affected by the paucity of
available donors.
In the vascular field, currently, the best graft performance is given by saphenous vein auto‐
grafts [1] whose main failures are related to thrombosis development, emboli production,
and intimal hyperplasia. Synthetic non-bio-resorbable vascular prosthesis (such as Dacron®
or extended-PTFE) exhibited very low incidences of thrombosis or hyperplasia and showed
good clinical results in medium- and large-diameter graft sites.
Strategies based on polymeric materials (synthetic or natural) appear to be a valid alterna‐
tive for the production of tissue graft materials. However, synthetic polymers are not able to
induce any biological response leading to tissue regeneration, due to the lack of biomimetic
activity. On the contrary, natural biodegradable polymeric supports, resembling extracellu‐
lar matrix component, can provide a useful platform in tissue engineering and regenerative
medicine applications [2-5].
© 2013 Romani et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Among them, chitosan (CS) a biodegradable [6], non-amphiphilic polymer of D-glucosamine
obtained by partial de-acetylation of chitin [3], has shown interesting properties including bio-
mimetism due to the similarity of is structure with that of glycosaminoglycanes [4].
Kind et al. [7] reported that it promotes plasma protein adsorption, platelet adhesion and ac‐
tivation, and thrombus development [8]. The positive charged CS surface induces a great
degree of platelet adhesion. In fact, the Food and Drug Administration approved its use as
haemostatic dressing for reducing haemorrhage [9-11]. Furthermore, it has been reported
that the negatively charged-modified surface of CS prolongs clot formation after re-calcifica‐
tion of plasma [12].
Up to now, few data, often conflicting, on the haemocompatibility of negative charged-
modified surfaces of CS films are available[11,12].
In a previous work [13] we developed novel CS hydrogel prepared in the presence of phos‐
phate salts and relatively high amount of disaccharides such as D-(+)raffinose or D-(+)sac‐
charose and investigated the physico-chemical characteristics as well as the
cytocompatibility of films obtained with this hydrogel. These sugars were not retained in
the final structure of the film but were able to act as viscosity modifiers during the solidifica‐
tion/gelation process. The interference of salts and disaccharides resulted in smooth, amor‐
phous film with improved hydrophilicity and cytocompatibility compared to CS films
produced with the same procedure but in low viscosity milieu. Differentiated human cells
showed a great affinity for these sugar-modified chitosan (smCS) films, thus suggesting
their candidature as promising biomaterial for tissue regeneration and repair.
The aim of the present study was to investigate qualities and aspects of the haemocompati‐
bility (platelet activation, haemolysis and activation of coagulation cascade) of smCS films
produced according to Bettiniet al. [13]. Moreover, the cytotoxicity of fragmented smCS was
investigated in view of its bio-resorbability.
These films were compared to materials able to activate platelets and induce thrombus for‐
mation such as plastic (standard polystyrene for cell culture) and glass (cover slips) as well
as a material able to trigger cell death such as latex.
2. Methods
2.1. Production of sugar-modified chitosan films
Chitosan solution was prepared as described in [13]. Briefly, four grams of chitosan powder
(Chitosan 95/50 HMC+, Germany) were dissolved in a 1% (w/v) acetic acid aqueous solution
until complete dissolution. Dibasic sodium phosphate (7.5 mM), sodium dihydrogen phos‐
phate (22 mM), potassium dihydrogen phosphate (1.5 mM), sodium chloride (125 mM) and‐
potassium chloride (2mM) were then sequentially added. The solution was filtered under
vacuum using a 0.8 μM filter. Finally, D-(+) raffinose pentahydrate (290 mM) or D-(+) su‐
crose (290 mM) were added to the solution and allowed to dissolve for 2 hours under gentle
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stirring. About one mL of this solution was poured into a circular mould (1 cm diameter)
and dried at 45 °C for 45 minutes in a ventilated oven. The obtained dry film was placed in a
5% (w/v) KOH aqueous solution for 12 hours then, washed in distilled water until neutrality
of the wash water.
2.2. Wettability
Contact angle measurements were performed at room temperature with a goniometer (AB
Lorentzen & Wettre, Germany) on the surface of smC film in comparison to glass cover slip
and plastic (standard polystyrene culture plates) to evaluate the wettability of the surface.
Briefly, a drop (4 μL) of human serum was placed on the surface of the specimen. Images of
the serum drop were recorded within 10 seconds of deposition by means of a digital camera
(FinPix S602 Zoom, Fuji film, Japan). Digital pictures were analysed by ImageJ 1.43v soft‐
ware (NIH, USA) for angle determination. At least five measurements, taken at different po‐
sitions on each specimen, were carried out on both left and right side of the drop and
averaged.
2.3. Atomic force microscopy
Atomic force microscopy (AFM) images of the films were analysed by AFM Nanoscope IIIA
(Digital Instruments Inc., USA). Point probe silicon cantilever tip was used in contacting
mode by the accompanying software to determine the surface roughness of investigated
surfaces. The roughness parameters of each sample was evaluated on three scanned areas of
10μm x 10μm each.
2.4. Procurement and processing of blood perfusates
This procedure was conducted in accordance with the tenets of the Declaration of Helsinki.
Following the indication of Italian DLgs no.196/03 (Codex on Privacy) in order to guarantee
the respect of the privacy of the patients and the confidentiality of the donors’ information.
Blood (3.5-4 mL/test) was drawn by venipuncture from four healthy volunteers and added
with tri-sodium citrate (0.109 M, 3.2% final concentration) in a 9:1 volumetric ratio to pre‐
vent coagulation. Whole blood was used for the haemolysis and thrombus formation tests.
Platelet-rich plasma (PRP) was obtained by centrifugation (400xg for 10 minutes, at room
temperature) while platelet-poor plasma (PPP, platelets less than 10.000/μL) by centrifuga‐
tion at 2000xg for 20 minutes at room temperature.
Coagulation- and factor XII-assays were performed with platelet-poor plasma isolated from
whole blood. For platelet function studies, PRP was volume adjusted with PPP to obtain a
final physiologic stock platelet count of 3 105 platelets μL-1.
2.5. Cell proliferation
Human endothelial cells derived from foetal umbilical vessels (HUVEC) were provided by
the American Type Culture Collection (Rockville, MD, USA). Cell monolayer were cultured
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in complete medium (D-MEM containing antibiotics and 10% foetal calf serum) supplement‐
ed with 50 μg mL-1 of endothelial cell growth factor (Sigma-Aldrich, USA) and kept in a in‐
cubator at 37 °C in a water-saturated atmosphere with 5% CO2. Endothelial cells were
seeded onto smCS films as well as on tissue culture plates (TCPS, Corning, USA) or glasses
(20x20 mm, ForLab, Carlo Erba, Italy,) at a density of 1–2.5 104 cells cm-2 in 24-well plates.
After 1, 3 and 7 days, the monolayer was rinsed twice with phosphate buffer solution, PBS,
and cells detached from the substrate by 0.02% trypsin in PBS. The number of adherent cells
was then, counted with a Burkerhaemocytometer.
2.6. Cell morphology
For morphological characterization, endothelial cells cultured on smCS films were examined
by contrast-phase microscopy. After 7 days, the cell monolayer adherent to the film was
gently washed with PBS three times. Then, the film was fixed with 2.5% glutaraldehyde in
PBS for 1 h at 4 °C. After thorough washing with PBS, the cells were dehydrated through
graded alcohol series and positioned under the microscope (Zeiss AxioPhot, Germany) for
observation and image recording (Zeiss AxioCam, Germany).
2.7. Cytotoxicity test
Endothelial cells were grown until confluence. The smCS films was cut in small pieces (0.5x0.5
mm) and placed in direct contact with the cell layer for 72 hours. Cells were detached and the
resulting suspension was counted in a Burkerhaemocytometer after proper dilution.
Duplicate cell counts on each suspension from 3 culture wells were performed for each sub‐
strate investigated. Not less than 50 cells were scored for each counting. Counts from tripli‐
cate seeding differed by not more than 10% among replications throughout the experiments.
2.8. Haemolysis assay
Two positive controls, copper and deionised water, and a negative control, glass cover slip,
were used in this study, SmCS films were dried and washed three times with PBS and then
sterilized by soaking in 75% (v/v) ethanol for 15 minutes. Then, washed 5 times in sterile PBS
and kept in the same buffer until use. Thereafter, the samples were put in vacutainers contain‐
ing sodium citrate (0.109 M, 3.2% w/v final concentration) (Greiner Bio-One International AG,
Austria) in which 3.5 mL of healthy volunteers blood was finally collected. The substrates were
incubated with blood at 37 °C, with gentle shaking twice every 30 minutes. After 3 hours, 1.5
mL of each vacutainer was centrifuged at 740xg for 10 minutes at room temperature. The ob‐
tained pellet was re-centrifuged at 3000g for 15 minutes at room temperature. The haemolyses
was quantified on a ADVIA 2120 system (Siemens-Bayer, Germany) using a colorimetric assay.
2.9. Coagulation assays
Human whole blood (3.5 mL) from a healthy volunteer was collected and mixed with an
aqueous solution containing sodium citrate, then the human whole blood was centrifuged at
1500g for 15 min at room temperature to separate the blood corpuscles, and the resulting
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PPP was used to study the coagulating ability of the CS film. All tests were performed on IL
Coagulation and ELECTRATM system (Instrumentation Laboratories, USA). The level of Pro‐
thrombin Time (PT), activated Partial Thromboplastin Time (aPTT) and Thrombin Time (TT)
were determined by using three different kits (Instrumention Laboratory USA): HemosIL TM
RecombiPlasTin 2G is a high sensitivity thromboplastin reagent based on recombinant hu‐
man tissue factor (RTF) for the quantitative determination in human citrate plasma of Pro‐
thrombin Time (PT); HemosIL TM SynthASil is a high synthetic phospholipids reagent for the
in vitro determination of APTT (Activated Partial Thromboplastin Time). After incubation at
37 °C for an optimized period of time, calcium is added to trigger the coagulation process
and the time required for clot formation is determined; HemosIL TM Thrombin Time was
used for the determination of TT in human citrated plasma.
2.10. Erythrocytes adhesion assay
SmCS films (10x10 mm) were equilibrated in PBS for 1 hour at 37°C. A washed-erythrocytes
stock suspension containing 3 105 mL-1 was poured on plastic and smCS film surfaces and
incubated for 30 minutes. The incubation volume was kept low (100 μL) to (a) minimize the
floating population of erythrocytes and (b) maintain the total erythrocytes count at a level
such as to prevent saturation-levels of adhesion and (c) to prevent other still suspended er‐
ythrocytes from contacting the surface. After that, the specimens were rinsed with PBS,
fixed with glutaraldheyde and detached from surface with 1% sodium dodecyl sulphate,
SDS. Ten microliters of recovered erythrocytes suspension were counted with a Burkerhae‐
mocytometer.
2.11. Platelet adhesion assay
SmCS films, plastic and cover slips glass were sterilized with 75% (v/v) ethanol solution.
Then air dried under a laminar-flow hood and rehydrated with 1 mL of sterile PBS for 1
hour. The surfaces were overlaid with 300 μL PRP at 37 °C for 2 hours. Then, the films were
washed three times in PBS with mild shaking to remove non- or poorly-adherent platelets.
After that, the specimens were rinsed with PBS, fixed with glutaraldheyde and cells detach‐
ed with 1% SDS. Ten microliters of recovered platelets suspension were counted with a Bur‐
kerhaemocytometer.
3. Platelet immunofluorescence
The platelet count in the PRP was adjusted to 300.000 μL-1 by dilution with homologous PPP.
After 1 hour contact of PRP with the different specimens at 37 °C, samples were washed with
PBS, followed by fixation with 3% (w/v) paraformaldehyde and incubated with 1% (w/v) BSA
in PBS. Labelling of the platelets was performed with a mouse monoclonal antibody CD62P
(anti-P-Selectin, Santa Cruz Biotechnology, USA) at dilution 1:100, followed by 1:200 diluted
monoclonal goat anti-mouse IgG antibody, FITC conjugated (Sigma-Aldrich, USA).
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4. Platelet morphology
The platelets-coated testing surfaces were fixed with freshly prepared 2.5% glutaraldehyde
for 20 minutes. After washing with PBS, the samples were dehydrated in a graded-ethanol
series (50, 70, 90, and 100% v/v) for 15 minutes each and allowed to dry at room tempera‐
ture. The platelet-attached surfaces were carbon sputter coated under vacuum to a thickness
of 100–200 Å and examined at 10 kV using a Cambridge StereoScan 200 microscope (Cam‐
bridge Scientific Instruments, UK).
4.1. Platelet aggregation
The blood samples were collected in tubes containing PPACK (D-phenylalanyl-L-prolyl-L-
arginine chloromethyl ketone) as anticoagulant. Platelet aggregation was measured by
means of light transmission aggregometry using Born’s turbidimetric procedure and the
PPACK-4 Platelet Aggregation Chromogenic Kinetic System (Helena Laboratories, USA).
Briefly, 250 μL of PRP were incubated with specimen surfaces for 10 (baseline) and 60 mi‐
nutes. Thereafter,the PRP were placed in a cuvette containing a metal stir bar in the absence
or in the presence (positive control) of the pro-aggregation agent, adenosine diphosphate
(ADP) 20 μM. Upon the addition of ADP the platelets started to aggregate thus increasing
light transmission through the sample. The degree of platelet aggregation was expressed as
the maximum percentage change in light transmission from PPP used as baseline. The ob‐
tained values were expressed as mean of two measurements.
4.2. Complement activation assay
The test, based on Complement Reagents Kit (Siemens Healthcare Diagnostic, Germany)
was performed on BCT Siemens coagulometer (Siemens, Germany). The test focused on the
ability of the complement system to lyse a standard suspension of sheep erythrocytes, sensi‐
tized with a rabbit anti-serum against sheep erythrocytes. Briefly, 1 mL of fresh blood sam‐
ples previously incubated for 1 hour with different substrates were incubated with
sensitized erythrocytes to investigate the complement activation. Diminished levels of indi‐
vidual components (e.g. due to prior activation by a foreign surface) result in a prolongation
of the time taken for lyses. The time necessary for the lyses of a defined amount of erythro‐
cytes is used as basis for determining the complement activity [14,15]. The results were eval‐
uated using a reference curve prepared by a serial dilution of standard plasma with isotonic
saline to give 100% of complement activity, 75% (75% of plasma + 25% saline) down to 10%
of complement activity (10% of plasma + 90% saline).
4.3. Statistical analysis
Data were expressed as means ± standard deviation (SD). Where not differently stated,
measurements were conducted at least in triplicate. Chi-square test or Student’s t-test on un‐
paired data was used to assess the statistical significance of the difference between the re‐
sults obtained from the tested specimens (Kaleida-Graph, Synergy Software, USA).
Statistical significance was assumed at a confidence level of 95% (p < 0.05).
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5. Results
5.1. Physico-chemical characterisation
As already stated, the sugar added to the chitosan solution during the preparation of the
smCS film was not retained in the final structure of the film.This assumption was mainly
based on FT-IR spectra analysis for the identification of the absorption bands relevant to vi‐
bration of functional groups of chitosan [13]. The addition of phosphate salts and D-(+) raffi‐
nose to the chitosan solution used for film preparation led to non dramatic modifications in
the IR spectrum of chitosan. The observation of the 1700-1500 cm-1 region evidenced that the
amide I band (C=O in amide group) wavenumber was lower than the value for chitosan
powder (1664 cm-1) for all the prepared films and particularly for those prepared from a sol‐
ution that did not contain the sugar [13]. This was interpreted as the result of a lower mobili‐
ty of the C=O group in the film due to its involvement in the week bound formation in the
solid structure. The incorporation of phosphate salts and significant amount of sugar in the
chitosan solution used for film preparation reduced this effect. On the other hand, the amino
group band of films prepared from a solution that did not contain the sugar was at a lower
wavenumber (1588 cm-1) than from chitosan powder (1592 cm-1), while it was practically un‐
changed in film prepared from the sugar containing solution (1590 cm-1).
D-(+)raffinose FT-IR spectrum evidenced characteristics bands at 2936 and 1649 cm-1. Inter‐
estingly, no trace of this bands was found in the FT-IR spectra of the chitosan film prepared
from solutions containing D-(+)raffinose. Similarly, no trace of the characteristic series of
peaks between 2994 and 2914 cm-1 of the sucrose powder was found in the spectrum of the
film prepared from a solution containing a high amount of sucrose [13].
These observations allowed to conclude that the excipients added to chitosan in the film
forming solutions though not retained in the solid film, interact or interfere with chitosan
chains during the film formation likely acting as viscosity modifiers during the solidifica‐
tion/gelation process.
5.2. Wettability
Contact angle measurements were performed by using serum droplets on plastic surface
and on smCS film. As expected, plastic showed the least wettable surfaces with significantly
higher contact angle (50° ± 6.3) compared to smCS film (15° ± 0.1) (Chi Square P< 0.001), thus
confirming the high hydrophilicity of smCS [13].
The hydrophilicity of the sm CS film was also investigated by measuring the swelling index
in water at the equilibrium according to the following equation:
100s dw
s
W WS xW
-= (1)
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where Ws and Wd represent the weight of the fully hydrated and the dry film respectively.
The smCS film afforded a degree of swelling at the equilibrium more than 3 order of magni‐
tude (1285%) higher than that of the dry film. These data confirmed the very high hydrophi‐
licity of the films obtained by adding a sugar to the solution used for the film preparation.
5.3. Roughness (AFM measurements)
The AFM analysis (Figure 1) revealed that the plastic specimen exhibited rather low surface
roughness (average= 28 nm) in contrast to smCS film that showed a roughness approximate‐
ly 1.7-fold higher, around 50 nm. It is interesting to note the almost regular appearance of
groove and pits in smCS compared with plastic surface.
 
Figure 1. AFM 3D image of (A) standard colture plastic dish (plastic) and (B) smCS film surfaces.
5.4. Adhesion and proliferation assay of endothelial cells
As shown in Figures 2 endothelial cells attached (A), extended and proliferated (B) very well
on all surfaces tested. Cell attachment (panel A, C) and proliferation (panel B) on smCS films
were comparable to control cells grown on standard tissue culture surface (plastic). Con‐
trast-phase microscopy showed that cells were well attached to the different surfaces and
closely packed maintaining their original shapes. Moreover, endothelial cells did not evi‐
dence any morphological indication of cell death 72 hours after seeding (panel D). The
counts of cells showed little variation for the three surfaces used. In the case of plastic sur‐
face (control) the growth of HUVEC reached the values of 21284 ± 650 cm-2, while in the case
of smCS reached a lower value of 19805 ± 305 cm-2 similarly to that obtained on glass surface
(19543 ± 1050 cm-2).
5.5. In vitro cytotoxicity
Data relevant to cell growth in the presence of small pieces of smCS film or latex (positive
control) are reported in Table 1.
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Figure 2. A) Percentage of cells adhered after 24 hoursand (B) proliferation assay of endothelial cells on the different
surfaces tested. Pictures taken at the optical microscope, in phase contrast (40x), showing the morphology of endo‐
thelial cells 8 hours (C) and 72 hours (D) after seeding on smCS film.
Hours after seeding
0 24 48 72
Latex (positive control) 10000 (± 239) 924 (± 25) 714 (±16) 50 (±30)
smCS 10000 (± 360) 11420 (±100) 16070 (±290) 18570 (± 200)
Table 1. Number of endothelial cells attached to the different substrates in the presence of latex or smCS film
fragments.
The initial plating corresponds to the number of cells attached to the substrate 6 hours after
their inoculation into the well. The measured plating efficiency was around 95%. When
smCS fragments were present in the colture medium, a progressive increase of cell numbers
was observed, while in the presence of latex a progressive detachment was noticed with al‐
most all plated cells detached from the substratum after 72 hours.
These results indicate that smCS film were not cytotoxic while latex, as expected, was found
to markedly affect endothelial cell survival.
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5.6. Haemolysis assay
Haemolysis of red blood cells was used to evaluate the membrane damaging potential of the
surface of the smCS film. Two positive controls, distilled water and Copper, and one nega‐
tive control, glass, were used.
Substrate Haemolysis (%)
Distilled Water 97 (± 5)
Copper 7 (± 2)
Plastic 5 (± 1)
Glass 2 (± 1)
smCS 1 (±3)
Table 2. Percentage of haemolysis measured on different substrates. The tested surfaces were incubated with whole
blood for 1 hour. Distilled water was used as positive control.
As shown in Table 2, distilled water resulted in about 100% haemolysis, while Copper led to
7% haemolysis. Glass and smCS film caused negligible haemolysis (within the experimental
error) indicating very low membrane damaging properties of smCS material.
5.7. Blood coagulation assay
The effects of the biomaterial on coagulation process were tested by means of the (aPTT), the
(PT) and the (TT) selected as reliable measurements of the capacity of blood to coagulate
through the intrinsic, extrinsic and common coagulation mechanisms, respectively. As
shown in Figure 3 the values obtained for PT, TT and aPTT were similar to those observed
for human plasma, thus indicating that all materials tested, including smCS, did not affect
coagulation pathways.
Substrates Erythrocyte lyses time (seconds)
Plasma (control) 35.4
Glass 38.2
Plastic 35.7
SmCS film 36.3
Table 3. Erythrocyte lyses time determined by plastic and glass surfaces in comparison with smCS film.
5.8. Complement activation assay
The erythrocyte lyses time observed and reported in Table 3 shows no significant difference
among the material studied and the control. The data presented demonstrate that smCS is a
nonreactive biomaterial that does not directly activate complement.
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Figure 3. Effect of the different surfaces on coagulation time tested by means of the (aPTT), the (PT) and the (TT).
5.9. Erythrocytes and platelets adhesion assay
In Table 4 the number of cells detached with SDS from the different surfaces after adhesion
test is reported. The smCS film presented a lower overall erythrocyte and platelet adhesion
in comparison to plastic surface.
Materials Surface Adhesion
Erythrocytes µL-1 Platelets µL-1
Plastic 40 (± 13) 11(± 8)
Glass - 17 (± 6)
smCS 8 (±3) 5 (± 2)
Table 4. Numbers of erythrocytes and platelets adhered to the studied surfaces
The test showed a high significant difference in the number of adhered erythrocytes on ma‐
terials studied (p<0.0001): the erythrocyte adhesion on smCS film was about 5 fold less than
the adhesion on plastic surface. A similar behaviour was observed for platelets. In fact, the
platelets recovered from plastic and glass surfaces ranged from 2 to 3 fold more than plate‐
lets recovered from smCS film surface.
5.10. Platelet aggregation
This test was performed in order to investigate the ability of plastic, smCS film and glass
surfaces to induce platelet aggregation. The presence of ADP (adenosine-diphosphate, a
pro-aggregation agent) determined a normal profile of platelets aggregation (range 90-95%
after 5 minutes of incubation). Subsequently, the influence of materials on platelets aggrega‐
tion in the absence of ADP was studied. There were no differences between materials ob‐
In vitro Blood Compatibility of Novel Hydrophilic Chitosan Films for Vessel Regeneration and Repair
http://dx.doi.org/10.5772/52706
167
served at baseline (10 min) and after 1 hour of incubation with the substrates. smCS induced
slightly higher aggregation of platelets (5-6%) compared to plastic (2.5%) or glass (less than
2%). However, these differences have to be considered with caution, as the coefficient of var‐
iation estimated with human plasma in the absence of ADP was around 10%.
Figure 4. Fluorescence microscopy (100X)images of human platelets immunodecorated with CD62P (p-Selectin). Ar‐
rows indicate the presence of pseudopodia.
5.11. Platelet activation assay
Platelet activation was studied by the membrane expression of P-Selectin using the CD62P
antibody. The expression of P-Selectin was evident on platelets adherent to plastic and glass
surfaces and was negligible on platelets settled on smCS films (Figure 4).
On glass and plastic (see arrows) the analysis of morphology showed several fully spread
platelets expressing pseudopodia with the occurrence of focal clumps. This was also evident
when platelets were examined by Scanning Electron Microscopy, SEM (Figure 5B and 5C).
SmCS film (Figure 5A) induced very limited morphological changes over the 90 minutes of
contact: platelets remained mostly discoid without the occurrence of pseudopodia.
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Figure 5. Scanning Electron Microscope images of platelets incubated onto different surfaces. (A) smCS film, (B) plas‐
tic, (C) glass.
6. Discussion
For blood-contact applications, haemocompatibility is largely determined by specific inter‐
actions with blood and its components [16]. Many, if not all, blood-contacting biomaterials
are able to cause different undesired host responses like thrombosis, inflammatory reactions
and infections.
The coagulation system and platelets are the main factors for thrombus formation on bioma‐
terials and represent a major unmet problem in the design of vascular implants and blood-
handling systems [17].
It is known that the endothelium is an active organ that maintains vessels integrity and pre‐
vent thrombosis and intimal hyperplasia [18,19]. Hence, biomaterials able to promote in situ
endothelialisation of implants would be highly desirable.
Studies involving in vitro endothelialisation of grafts with cultured endothelial cells prior
to implantation have shown that a confluent endothelium is able to prevent trombogenic
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complications and improves long-term patency [20,21]. Thus, taking into account that the
endothelialisation of the blood-contacting polymeric materials is  an important pre-requi‐
site for the success of the synthetic vascular grafts [22] we firstly investigated the ability
of  endothelial  cells  to  adhere  and  proliferate  on  smCS  film.  The  results  obtained,  in
agreement  with  those  shown  in  our  previous  paper  [13],  showed  only  little  variation
among the surfaces tested (glass, plastic and smCS). However, from the cell proliferation
and  morphology  it  was  very  difficult  to  discriminate  difference  in  cytophilicity  among
the  surfaces  tested.  Furthermore,  the  presence  of  fragmented smCS did not  induce  any
decrement in the total number of endothelial cells compared to latex that, on the contra‐
ry, strongly affected cell survival.
The high hydrophilicity of smCS, indicated by the low contact angle, could ease the interac‐
tion with the bipolar extra-cellular matrix proteins such as fibronectin and vitronectin. Fur‐
thermore, the reduced cationic nature, due to a water shell does not allow anionic proteins
such as collagen and fibronectin to dissociate from CS surface in a physiological environ‐
ment. This aspect is in agreement with the conclusion of [23] who reported that a hydrophil‐
ic surface is good for anti-non-specific protein adsorption. It was recently reported that the
affinity for water of the cell-material interface seems to be a chief parameter in controlling
cell adhesion, migration and differentiation [24].
Stevens and George [25] recognized that cells are sensitive to microscale patterns of chemis‐
try and topography, and Dalby [26] noted that cell behaviour is directly influenced by the
surface structures such as grooves, pits, or ridges.
In this paper AFM images of smCS films evidenced a topographically patterned surface. In
the light of the above reported literature, this observation can be used to speculate about the
enhanced adhesion and proliferation of vascular cells compared to conventional, CS films
previously observed in [13].
Surface properties such as wettability, surface topography and charge are known to affect
endothelial cells attachment and growth [8]likely by altering the rate of the amount of adsor‐
bed proteins and their conformational changes [27,28]. The effect of surface materials on er‐
ythrocyte aggregation and platelet adhesion/activation becomes a chief parameter in
haemocompatibility studies.
Several years ago Malette and co-workers [29] ascribed the pro-coagulation properties of
chitosan to the negative charged surface of erythrocytes, while [30]showed that chitosan
may induce the adhesion of erythrocytes.
In the present study, the surface of smCS films induced only a limited erythrocytes agglom‐
eration, thus indicating that smCS surface neither captures erythrocytes nor forms a three-
dimensional network structure with these cells.
The lack of erythrocyte aggregation may be likely due to a polymer chains rearrangement
that masks the cationic nature of chitosan surface. Such a rearrangement can be ascribed to
the larger amount of water in smCS films as described in [13].
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One of the most important findings of this work is the observed difference in platelets mor‐
phology seeded on smCS in comparison with glass or plastic. On the latter surfaces platelets
appeared flat with interconnecting pseudopodia coupled to strong P-Selectin membrane ex‐
pression.On the contrary, the platelets on smCS films were discoidal, and neither pseudopo‐
dia formation nor a P-Selectin membrane translocation was observed.
This finding could be attributed to a new conformation of the adsorbed plasma proteins on
glass or plastic that could have facilitated platelet aggregation. Indeed, it is well known that
the surface topography can induce a spatial reorganization of adsorbed proteins as well as
how this phenomenon occurs [31]. In contrast, when the adsorbed proteins maintain their
native state, they do not support platelet adhesion and aggregation [32].
The absence of platelet activation on smCS surfaces suggests this outcome.
As far as the surface morphology is concerned, it has been reported that platelets adhere in
similar manner on smooth and rough surfaces when tested under static conditions [33]. Sim‐
ilarly Ward et al. [34] concluded that it is not the roughness per se which affects the platelet
adhesion.
One decade ago, Suzuki and Minami [35,36] showed that Chitosan depleted complement
proteins from plasma, suggesting that chitosan activates complement. A greater depletion of
complement activity was seen for a highly de-acetylated form of chitosan [36]. It is however,
important to note that the results obtained about the complement activation were based on
binding and depletion assays. This complement depletion can equally be explained by as‐
suming a tight binding to the chitosan surface without activation [37].
The results presented here indicate that although large amounts of serum were deposited on
smCS surface no activation of the complement system occurred, suggesting that the comple‐
ment is not directly activated by the smCS surface in the process of blood coagulation.
Haemolysis testing of biomaterials has been advocated for, and used in, standard biological
safety testing of materials for more than 30 years. The results of test for haemolysis should
be considered with care even if they represent the only recommended test for some medical
devices as stated in Part 4 of ISO 10993 guideline.
Different papers have reported that chitosan promotes surface-induced haemolysis likely
through an electrostatic interactions [38]. In the present work, in the presence of whole
blood smCS triggered less than 5% of haemolysis that, along with the low erythrocyte adhe‐
sion, indicates a wide safety margin in blood contacting applications and suitability for vas‐
cular implants.
In the process of haemostasis, the activation of platelet adhesion and aggregation could rep‐
resent an initial and critical step. Here we showed that the surface of smCS films does not
interfere with coagulation mechanism and supportswell endothelial cell adhesion and pro‐
liferation even if [39] reported that the haemostatic mechanism of chitosan may be inde‐
pendent of the classical coagulation cascade.
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7. Conclusion
In this paper we demonstrated that the simple introduction of a viscosity modifier, such as a
polysaccharide, during the process of production of chitosan films affords chitosan struc‐
tures (smCS film) with improved capability to induce surface endothelialisation.
This structure is moreover, characterized by a high degree of haemocompatibility and does
not induce clots formation.
These findings are of particular interest as they add new information with respect to the
presently available literature and they put new light on the use of chitosan for producing
surfaces that has to get in contact with blood.
As a matter of fact, the haemostatic properties of chitosan have to be considered more care‐
fully as we have demonstrated that they could be dramatically reduced by an improvement
of the hydrophilicity of the chitosan film surface.
Finally, from the results presented in this work, we can conclude that the sugar modified
chitosan film could be envisaged as a new material for the design the luminal portion of ves‐
sel prosthesis based on a natural and bio-resorbable polymer.
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